(Q43936583)

28 November 2017

title

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes (English)

1 reference

28 November 2017

0 references

1 reference

H M Colhoun

1

1 reference

28 November 2017

M J Thomason

2

1 reference

28 November 2017

M I Mackness

3

1 reference

28 November 2017

S M Maton

4

1 reference

28 November 2017

D J Betteridge

5

1 reference

28 November 2017

P N Durrington

6

1 reference

28 November 2017

G A Hitman

7

1 reference

28 November 2017

H A W Neil

8

1 reference

28 November 2017

J H Fuller

9

1 reference

28 November 2017

Collaborative AtoRvastatin Diabetes Study (CARDS)

10

1 reference

28 November 2017

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

19

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

201-211

1 reference

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Long-term prognosis after myocardial infarction in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

International variations in cardiovascular mortality associated with diabetes mellitus: the WHO Multinational Study of Vascular Disease in Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Lipids, diabetes, and vascular disease: the time to act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Retinopathy predicts coronary heart disease events in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Communicating the risk reduction achieved by cholesterol reducing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Lipid-lowering therapy in low-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00643.X

10.1046/J.1464-5491.2002.00643.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference